Karli Hubka, OD
NPI 1740662972 · Optometrist · Clay Center, KS
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Karli Hubka, OD is a Optometrist provider in Clay Center, KS (NPI 1740662972).
Provider details
- NPI number
- 1740662972
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- OD
- Sex
- Female
- Sole proprietor
- No
- License
- 2007 (KS)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
10 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
870 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 366 | $119 |
| Photography of the Retina92250 | 182 | $34 |
| Exam of Visual Field With Extended Testing92083 | 86 | $58 |
| Imaging of Optic Nerve92133 | 73 | $31 |
| Imaging of Retina92134 | 68 | $37 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 49 | $84 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 142 | 27 |
| Prednisolone Acetate | 29 | 27 |
| Timolol Maleate | 28 | — |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 16 | — |
| Brimonidine Tartrate/Timololbrand: Combigan | 14 | — |
| Tobramycin/Dexamethasonebrand: Tobramycin-Dexamethasone | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2015-06-24
- Last updated
- 2015-06-24
Frequently asked questions
- What is Karli Hubka's NPI number?
- Karli Hubka's National Provider Identifier (NPI) is 1740662972, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Karli Hubka's specialty?
- Karli Hubka is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
- Where is Karli Hubka located?
- Karli Hubka's practice location on file with NPPES is 532 Lincoln Ave, Clay Center, KS 67432-2902.
- What is Karli Hubka's phone number?
- The practice phone number listed in the NPPES registry for Karli Hubka is (888) 749-7755.
- Does Karli Hubka accept Medicare?
- Karli Hubka is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Karli Hubka's NPI active?
- Yes — Karli Hubka's NPI (1740662972) is active in the NPPES registry as of the last update on 2015-06-24.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.